Pay in 4 interest-free payments of $7.18 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
the Institute for Clinical and Economic Review deemed current GLP-1 prices cost-effective only below USD 7,000 annually, prompting insurers to demand steep rebates
The company will likely provide an update on the future of its GLP-1 business during its earnings call Monday
PT-141 offers a legitimate medical option for premenopausal women with hypoactive sexual desire disorder, but it still carries cardiovascular and hormonal considerations that require professional oversight
This question concerns many patients prescribed this GLP-1 receptor agonist for type 2 diabetes or weight management
US$ 23.32
US$ 22.68
US$ 26.43
US$ 25.01
